Dental: Biolase gains on Q4 prelims
Dental devices maker Biolase gets some Wall Street love on positive cash flow expectations for Q4 2012.

Dental laser maker Biolase [1] (NSDQ:BIOL [2]) released a preliminary earnings report, expecting to positive cash flow for Q4 and the full year of 2012.
The optimistic outlook sent BIOL shares up 2.2% on the day to close at $2.77 from an open of $2.70 this morning.